StreetAlpha.app
Home › Stocks › BSX

Boston Scientific Corp (BSX)

Healthcare
$43.03
▼ −1.51%
LAST CLOSE · NOV 17

Boston Scientific develops, makes and sells medical devices for hospitals and other health care providers. It last closed at $43.03 on Nov 17, down 1.51% on the day. BSX reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 16 analysts is $50.06 (+16.3% from the last close), with a high of $65.00 and a low of $44.00. Analyst consensus is Buy, based on the latest ratings from 16 firms (11 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 12 whale options trades in BSX, 75% of them bullish and 25% bearish. In the past 30 days there were 21 dark pool prints totaling $64.9M, the largest $22.2M.

AI Auto Pilots
Is BSX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$21.1B
+8.9% vs a year ago
Net income
$3.5B
+25.5% vs a year ago
EPS (diluted)
$2.37
+26.7% vs a year ago
Free cash flow
$3.3B
15.8% margin
Valuation
Market cap
$62.4B
1.45B shares
P/E
18.2
Price over 12 month EPS
Price to sales
3.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$609.0M
At Sep 30
Shareholder equity
$25.6B
Shares outstanding
1.45B
At Oct 29
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $11.9B$11.9BFY2021FY2022: $12.7B$12.7BFY2022FY2023: $14.2B$14.2BFY2023FY2024: $16.7B$16.7BFY2024FY2025: $20.1B$20.1BFY2025

From BSX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 2). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$0.78
$5.18B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 16 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
16firms
11 Buy5 Hold0 Sell
Each firm's latest rating on BSX in the past 90 days
Average 12-month target
$50.06
▲ 16.3% upside

Based on 16 analysts who set a price target on BSX in the past 90 days. The average target is $50.06, with a high of $65.00 and a low of $44.00, compared with the last close of $43.03.

$40$49$58$67PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $65AVG $50.06LOW $44May 22LAST CLOSE+12 MO$40$49$58$67PAST 112 DAYSTARGETSHIGH $65AVG $50.06LOW $44May 22LAST CLOSE+12 MO
Highest target$65.00
Average target$50.06
Lowest target$44.00
Latest rating changes
TD CowenDowngrade
Oct 30Hold$56 → $46
BarclaysTarget lowered
Oct 30Hold$48 → $45
JefferiesDowngrade
Oct 29Hold$67 → $46
Canaccord GenuityTarget lowered
Oct 29Buy$66 → $48
BernsteinMaintained
Oct 29Buy$49
DateFirmActionRatingPrice target
Oct 30TD CowenDowngradeHold$56 → $46
Oct 30BarclaysTarget loweredHold$48 → $45
Oct 29JefferiesDowngradeHold$67 → $46
Oct 29Canaccord GenuityTarget loweredBuy$66 → $48
Oct 29BernsteinMaintainedBuy$49
Loading…

Technical Analysis

BSX · as of the Nov 17 close · updated after every close
Downtrend

The stock is 3% below its 20 day and 2% below its 50 day average. It is 25% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 45). The nearest support is the swing low (Sep 10) at $42.78, and the nearest resistance the Pivot at $43.29.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 3.7%/day
Key levels
$102.7152 week high+138.7%
$53.65200 day average+24.7%
$45.45Swing high (Jul 16)+5.6%
$45.39100 day average+5.5%
$44.2020 day average+2.7%
$43.8950 day average+2.0%
$43.56Pivot R1+1.2%
$43.29Pivot+0.6%
$43.03Last close
$42.78Swing low (Sep 10)−0.6%
$42.76Pivot S1−0.6%
$39.5752 week low−8.0%
Indicators
RSI (14)45.26Middle of its rangeNeutral
MACD-0.10Below its signal lineBearish
Stochastic48.5Middle of its rangeNeutral
ADX (14)12.7No clear trend
Williams %R-74.5Oversold below −80, overbought above −20Neutral
CCI (20)-63.3Oversold below −100, overbought above 100Neutral
Rate of change−1.1%Change over 10 sessionsBearish
ATR (14)$1.60Typical daily range, 3.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BSX

What happened before

See how BSX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish9 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow BSX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BSX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
12
Bullish
9
75%
Bearish
3
25%
Date span
Aug 24 – Nov 17
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
21
Notional
$64.9M
Largest print
$22.2M
Loading…

BSX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●781 buying vs 735 selling
  • ▼Held by funds -0.5 pts
  • ▲Funds holding +19
  • ▼Superinvestors: 1 added, 4 cut
  • ▼Put/call 0.25 to 0.34
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,5061,487+1.3%
In funds' top 101011−9.1%
Held by funds92.2%92.7%−0.5 pts
New / increased213 / 568132 / 591+8.0%
Reduced / sold out556 / 179613 / 327−21.8%
Put/call ratio0.340.25+36.6%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BSX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BSX Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$3.0B
4.8% of value
Shares outstanding, 12 months
−2.2%
Fewer shares
Last quarter
—
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $2.0B
Dec 2023: $0Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $2.0B, average price $50.10Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 2, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BSX is in one of them and how their past BSX trades turned out.

BSX in the AI portfolios
Loading…

BSX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BSX in an article yet. Here's the latest on the wider market.

BSX Congress Trades

All congress trades →
Trades, 12 months
65
Buys
36
55%
Sells
29
45%
People
9
Last filed Nov 5
Who traded BSX · since 2017
Latest 5 filings of 191
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
$50K – $100KTraded Sep 9, 2026Filed Sep 28, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CASell$1K – $15KSep 11, 2026Oct 7, 202626 d
Ro KhannaD · CASell$1K – $15KSep 4, 2026Oct 7, 202633 d
Kevin HernR · OKSell$50K – $100KSep 9, 2026Sep 28, 202619 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Boston Scientific

Boston Scientific develops, manufactures and markets medical devices used in procedures across several areas of health care. Its products are mainly bought by hospitals, physicians and other health care providers around the world, who are usually reimbursed for those procedures by government programs and private health plans. The company is based in Marlborough, Massachusetts, in the United States, and it competes with large device makers as well as smaller firms that focus on a few products.

Headquarters
Marlborough, MA
Founded
1979